Company Filing History:
4 out of 90 
2 out of 15,462 
1 out of 2,008 
Years Active: 1998-2015
Title: Biography of Inventor Karl H Weisgraber
Introduction: Karl H Weisgraber is a notable inventor based in Walnut Creek, California. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic antibodies and treatments for apolipoprotein E-related disorders. With a total of six patents to his name, Weisgraber's work has had a profound impact on medical research and therapeutic applications.
Latest Patents: Among his latest patents is the invention of synthetic antibodies specific for an epitope present on an apolipoprotein E polypeptide. This innovation provides valuable tools for various treatment, diagnostic, and monitoring applications. Another significant patent involves compounds that inhibit apoE4 domain interaction, which are crucial for treating disorders related to apoE4. These methods generally involve administering a therapeutically effective amount of an apoE4 domain interaction inhibitor to individuals in need.
Career Highlights: Karl H Weisgraber has had a distinguished career, working with prestigious institutions such as the J. David Gladstone Institutes and the University of California. His research has been pivotal in advancing our understanding of apolipoproteins and their role in various diseases.
Collaborations: Throughout his career, Weisgraber has collaborated with esteemed colleagues, including Yadong Huang and Robert L Raffai. These partnerships have fostered innovative research and development in the field of biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.